Correlation Between Quest PharmaTech and Atara Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Quest PharmaTech and Atara Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quest PharmaTech and Atara Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quest PharmaTech and Atara Biotherapeutics, you can compare the effects of market volatilities on Quest PharmaTech and Atara Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quest PharmaTech with a short position of Atara Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quest PharmaTech and Atara Biotherapeutics.
Diversification Opportunities for Quest PharmaTech and Atara Biotherapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Quest and Atara is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Quest PharmaTech and Atara Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atara Biotherapeutics and Quest PharmaTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quest PharmaTech are associated (or correlated) with Atara Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atara Biotherapeutics has no effect on the direction of Quest PharmaTech i.e., Quest PharmaTech and Atara Biotherapeutics go up and down completely randomly.
Pair Corralation between Quest PharmaTech and Atara Biotherapeutics
Assuming the 90 days horizon Quest PharmaTech is expected to under-perform the Atara Biotherapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, Quest PharmaTech is 2.25 times less risky than Atara Biotherapeutics. The pink sheet trades about -0.07 of its potential returns per unit of risk. The Atara Biotherapeutics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 7,125 in Atara Biotherapeutics on September 14, 2024 and sell it today you would lose (6,079) from holding Atara Biotherapeutics or give up 85.32% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Quest PharmaTech vs. Atara Biotherapeutics
Performance |
| Timeline |
| Quest PharmaTech |
| Atara Biotherapeutics |
Quest PharmaTech and Atara Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Quest PharmaTech and Atara Biotherapeutics
The main advantage of trading using opposite Quest PharmaTech and Atara Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quest PharmaTech position performs unexpectedly, Atara Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atara Biotherapeutics will offset losses from the drop in Atara Biotherapeutics' long position.| Quest PharmaTech vs. Coya Therapeutics, Common | Quest PharmaTech vs. Cue Biopharma | Quest PharmaTech vs. Lantern Pharma | Quest PharmaTech vs. Fennec Pharmaceuticals |
| Atara Biotherapeutics vs. Fate Therapeutics | Atara Biotherapeutics vs. Sana Biotechnology | Atara Biotherapeutics vs. Caribou Biosciences | Atara Biotherapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |